News

AIFA to pharmaceutical companies. Observations on scientific information guidelines

Guidelines on the advertising of medicinal products to healthcare professionals - expression of interest (03/16/2018)

Notice to Pharmaceutical Industry Associations

In accordance with article 119, paragraph 2, of Legislative Decree 219/2006, in which it is established that the guidelines on the advertising of medicines to healthcare professionals are adopted by AIFA, having consulted the pharmaceutical industry associations, it is invite the associations themselves to express their interest in receiving a copy of the draft [ed: draft] of the guidelines and to express their observations and comments.

To this end, it will be necessary to notify the AIFA Scientific Information Office (infomedicoscientifica@pec.aifa.gov.it) the PEC address of the association, as well as the name and contact details of the contact person(s), within 7 working days from the date of publication of this notice on the AIFA Portal.

Communications received from parties other than pharmaceutical industry associations (for example, individual companies, law or consultancy firms, etc.) will not be taken into consideration.

AIFA – 03/16/2018

Related news: Legislative Decree 219/06 Article 119

Guidelines of the "Regional regulation of scientific information on drugs"

ANAC. Guidelines Code NHS behavior.

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco